AU Patent

AU2011273728A1 — Needle shield for a safety device, safety device and injection device

Assigned to Sanofi Aventis Deutschland GmbH · Expires 2013-01-10 · 13y expired

What this patent protects

A needle shield (1.1) comprising at least two different plastic materials of different flexibility and a central aperture (1.1.3) of variable diameter (D1, D2). The central aperture (1.1.3) comprises a first diameter (D1) for retaining a needle cap (2.2) therein. The diameter of …

USPTO Abstract

A needle shield (1.1) comprising at least two different plastic materials of different flexibility and a central aperture (1.1.3) of variable diameter (D1, D2). The central aperture (1.1.3) comprises a first diameter (D1) for retaining a needle cap (2.2) therein. The diameter of the central aperture (1.1.3) changes upon removal of the needle cap (2.2) from the first diameter (D1) to a second diameter (D2) by virtue of a memory effect of the material of the needle shield (1.1). The needle shield (1.1) is made by an injection moulding process.

Drugs covered by this patent

Patent Metadata

Patent number
AU2011273728A1
Jurisdiction
AU
Classification
Expires
2013-01-10
Drug substance claim
No
Drug product claim
No
Assignee
Sanofi Aventis Deutschland GmbH
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.